CELU
Celularity Inc
$0.74
-0.01 (-1.07%)
At close · Jul 10
Market Cap
$21.43M
Shares
28,945,961
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.74
Open$0.78
Day$0.74–0.79
52W$0.56–4.35
Avg vol 30d162K
Short int413K · 1.4% float · 3.3d
Short vol23%
DataJan 2020–Jul 2026
Filing10-K · Apr 30
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Apr 30, 2026
Equibles Rating
blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Poor
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−45%
below
Price vs 50-day avg
−9%
below
RSI (14)
49
neutral
MACD trend
Positive
52-week position
5%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−4%
trailing
6-month return
−43%
trailing
YTD return
−33%
this year
Relative strength
−52%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Flat
1 of 38 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.43% of float · ▲ +10.2% MoM · 3.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
38 holders — near 2-yr high, broad support
Squeeze score
55
elevated · 0–100
Fundamentals
Revenue growth
−51%
Y/Y
Gross margin
25%
expanding
EPS growth
−36%
Y/Y
Free cash flow
$-13.4M
Balance sheet
$70.3M
net debt
Quant / Vol
risk profile
Volatility
104%
annualized · 1-yr
Max drawdown
−86%
past year
ATR
12.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−45%
Bearish
Price vs 50-day avg
−9%
Bearish
RSI (14)
49
Neutral
MACD trend
Positive
Bullish
52-week position
5%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Flat
1 of 38 funds reported for Jun 30 · net 0 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
1.43% of float · ▲ +10.2% MoM · 3.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
38 holders — near 2-yr high, broad support
Price context
position in its 52-week range
52-wk low $1
Now $1 · 5%
52-wk high $4
vs 200-day avg -45%
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CELU
this stock
Celularity Inc
|
$21.43M | -33.3% | -51.0% | — | 1.4% |
|
ONC
BeOne Medicines Ltd.
|
$431.70B | -1.7% | +22179.2% | 878.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.19B | +7.1% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.67B | -13.8% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$54.85B | +4.4% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CELU | +19.4% | -4.4% | -42.6% | +23.8% | -33.3% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | +18.0% | -8.5% | -51.7% | +22.7% | -44.0% |